We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 7.50 | 4.17% | 187.50 | 180.00 | 195.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 187.50 | 180.00 | 180.00 | 11,324 | 08:49:08 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -30.94M | -0.2958 | -6.34 | 188.32M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 02/12/2024 | 08:00 | UK RNS | Faron Pharmaceuticals Oy Interactions with UK Regulatory Authorities |
| 27/11/2024 | 11:29 | ALNC |  Faron announces promising findings from blood cancer drug trial |
| 27/11/2024 | 07:00 | UK RNS | Faron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB Trial |
| 11/11/2024 | 07:00 | UK RNS | Faron Pharmaceuticals Oy Targeting Soluble Clever-1 for Autoimmune Diseases |
| 05/11/2024 | 07:00 | UK RNS | Faron Pharmaceuticals Oy Shareholders’ Nomination Board |
| 22/10/2024 | 06:00 | UK RNS | Faron Pharmaceuticals Oy Faron’s Capital Markets Day 2024 |
| 07/10/2024 | 06:00 | UK RNS | Faron Pharmaceuticals Oy Faron announces Capital Markets Day |
| 30/8/2024 | 06:00 | UK RNS | Faron Pharmaceuticals Oy Grant of options |
| 27/8/2024 | 10:08 | ALNC | Faron Pharma shares surge as US FDA grants fast track designation |
| 27/8/2024 | 06:00 | UK RNS | Faron Pharmaceuticals Oy Faron 2024 Half-Year Financial Results |
1 Year Faron Pharmaceuticals Oy Chart |
Intraday Faron Pharmaceuticals Oy Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
